J. Silverberg, “Efficacy Comparison of Targeted Systemic Monotherapies Including Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: a Network Meta-Analysis”, J of Skin, vol. 8, no. 1, p. s313, Jan. 2024.